Clinical Usefulness of Plasma Interleukin-6 and Interleukin-10 in Disseminated Intravascular Coagulation.
10.3343/kjlm.2007.27.2.83
- Author:
Ji Weon SEO
1
;
Hyun Kyung KIM
;
Dong Soon LEE
;
Han Ik CHO
Author Information
1. Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea. hanik@snu.ac.kr
- Publication Type:Original Article ; English Abstract
- Keywords:
Disseminated intravascular coagulation (DIC);
Interleukin-6 (IL-6);
Interleukin-10 (IL-10)
- MeSH:
Adult;
Aged;
Blood Coagulation Tests;
Disseminated Intravascular Coagulation/blood/*diagnosis/mortality;
Female;
Humans;
Infection/blood;
Interleukin-10/*blood;
Interleukin-6/*blood;
Male;
Middle Aged;
Prognosis;
Survival Analysis
- From:The Korean Journal of Laboratory Medicine
2007;27(2):83-88
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Disseminated intravascular coagulation (DIC) is a syndrome characterized by a systemic activation of coagulation leading to the intravascular deposition of fibrin and the simultaneous consumption of coagulation factors and platelets. Inflammatory cytokines can activate the coagulation system. This study investigated the diagnostic and prognostic usefulness of the plasma level of interleukin-6 (IL-6) and interleukin-10 (IL-10) for predicting DIC. METHODS: The study populations were 15 healthy controls and 81 patients who were clinically suspected of having DIC and were requested to perform DIC battery tests. The presence of overt DIC was defined by the International Society on Thrombosis and Haemostasis Subcommittee cumulative score of 5 or above. The 28 day mortality was used to assess the prognostic outcome. The plasma levels of the cytokines were measured by ELISA. RESULTS: The plasma levels of IL-6 and IL-10 in patients (N=81) were higher than those of control (N=15). IL-6 and IL-10 levels of overt DIC group (N=31) were 3 times and 1.5 times higher than those, respectively, of non-overt DIC group (N=50). In infection group (N=48), IL-6 and IL-10 levels of overt DIC group (N=18) were 5 times and 3 times higher than those, respectively, of non-overt DIC group (N=30). The diagnostic efficiency of IL-6 (optimal cut off >40.4 pg/mL) and IL-10 (>9.7 pg/mL) for the diagnosis of overt DIC were 67% and 69%, respectively, which were similar to that of D-dimer. Plasma levels of IL-6 and IL-10 were also higher in non-survivors than in survivors. The patients with higher levels of IL-6 and IL-10 showed a poorer prognosis. CONCLUSIONS: The proinflammatory cytokine, IL-6 and anti-inflammatory cytokine, IL-10 were useful for the diagnosis of overt DIC and the prediction of its prognosis. These results also showed the evidence of a close interaction between coagulation and inflammation.
